866-997-4948(US-Canada Toll Free)

Global Neuromodulation Market Research Report 2016

Published By :

QYResearch

Published Date : Oct 2016

Category :

Biotechnology

No. of Pages : 102 Pages

Notes:
Production, means the output of Neuromodulation
Revenue, means the sales value of Neuromodulation

This report studies Neuromodulation in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Medtronic, Inc. (U.S.)
Boston Scientific Corporation (U.S.)
St. Jude Medical, Inc. (U.S.)
Synapse Biomedical, Inc. (U.S.)
Nevro Corporation (U.S.)
Neurosigma, Inc. (U.S.)
Neuropace, Inc. (U.S.).
Neuronetics, Inc. (U.S.)
Cyberonics, Inc. (U.S.)
BioControl Medical (Israel)
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Neuromodulation in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Internal Neuromodulation
External Neuromodulation
Type III
Split by application, this report focuses on consumption, market share and growth rate of Neuromodulation in each application, can be divided into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation Market

Table of Contents

Global Neuromodulation Market Research Report 2016
1 Neuromodulation Market Overview
1.1 Product Overview and Scope of Neuromodulation
1.2 Neuromodulation Segment by Type
1.2.1 Global Production Market Share of Neuromodulation by Type in 2015
1.2.2 Internal Neuromodulation
1.2.3 External Neuromodulation
1.2.4 Type III
1.3 Neuromodulation Segment by Application
1.3.1 Neuromodulation Consumption Market Share by Application in 2015
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Vagus Nerve Stimulation Market
1.4 Neuromodulation Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Neuromodulation (2011-2021)

2 Global Neuromodulation Market Competition by Manufacturers
2.1 Global Neuromodulation Production and Share by Manufacturers (2015 and 2016)
2.2 Global Neuromodulation Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Neuromodulation Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Neuromodulation Manufacturing Base Distribution, Sales Area and Product Type
2.5 Neuromodulation Market Competitive Situation and Trends
2.5.1 Neuromodulation Market Concentration Rate
2.5.2 Neuromodulation Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Neuromodulation Production, Revenue (Value) by Region (2011-2016)
3.1 Global Neuromodulation Production by Region (2011-2016)
3.2 Global Neuromodulation Production Market Share by Region (2011-2016)
3.3 Global Neuromodulation Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Neuromodulation Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Neuromodulation Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Neuromodulation Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Neuromodulation Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Neuromodulation Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Neuromodulation Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Neuromodulation Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Neuromodulation Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Neuromodulation Consumption by Regions (2011-2016)
4.2 North America Neuromodulation Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Neuromodulation Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Neuromodulation Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Neuromodulation Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Neuromodulation Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Neuromodulation Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Neuromodulation Production, Revenue (Value), Price Trend by Type
5.1 Global Neuromodulation Production and Market Share by Type (2011-2016)
5.2 Global Neuromodulation Revenue and Market Share by Type (2011-2016)
5.3 Global Neuromodulation Price by Type (2011-2016)
5.4 Global Neuromodulation Production Growth by Type (2011-2016)

6 Global Neuromodulation Market Analysis by Application
6.1 Global Neuromodulation Consumption and Market Share by Application (2011-2016)
6.2 Global Neuromodulation Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Neuromodulation Manufacturers Profiles/Analysis
7.1 Medtronic, Inc. (U.S.)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Neuromodulation Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Medtronic, Inc. (U.S.) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Boston Scientific Corporation (U.S.)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Neuromodulation Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Boston Scientific Corporation (U.S.) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 St. Jude Medical, Inc. (U.S.)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Neuromodulation Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 St. Jude Medical, Inc. (U.S.) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Synapse Biomedical, Inc. (U.S.)
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Neuromodulation Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Synapse Biomedical, Inc. (U.S.) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Nevro Corporation (U.S.)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Neuromodulation Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Nevro Corporation (U.S.) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Neurosigma, Inc. (U.S.)
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Neuromodulation Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Neurosigma, Inc. (U.S.) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Neuropace, Inc. (U.S.).
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Neuromodulation Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Neuropace, Inc. (U.S.). Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Neuronetics, Inc. (U.S.)
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Neuromodulation Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Neuronetics, Inc. (U.S.) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Cyberonics, Inc. (U.S.)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Neuromodulation Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Cyberonics, Inc. (U.S.) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 BioControl Medical (Israel)
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Neuromodulation Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 BioControl Medical (Israel) Neuromodulation Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview

8 Neuromodulation Manufacturing Cost Analysis
8.1 Neuromodulation Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Neuromodulation

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Neuromodulation Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neuromodulation Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Neuromodulation Market Forecast (2016-2021)
12.1 Global Neuromodulation Production, Revenue Forecast (2016-2021)
12.2 Global Neuromodulation Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Neuromodulation Production Forecast by Type (2016-2021)
12.4 Global Neuromodulation Consumption Forecast by Application (2016-2021)
12.5 Neuromodulation Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *